AiXin Life International, Inc. AIXN revenue by segment, product and geography
In its fiscal year ending 2025-12-31, AiXin Life International, Inc. reported revenue across 5 products and services; the largest, Manufacture And Sale, was $802K (-58.1% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Manufacture And Sale$802Kshare n/a-58.1% yoy
- Hotel$409Kshare n/a-30.2% yoy
- Direct Sales$172Kshare n/a-65.9% yoy
- Product$172Kshare n/a-65.9% yoy
- Pharmacies$107Kshare n/a-87.0% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Manufacture And Sale$136K45.0%no prior
- Hotel$136K44.9%no prior
- Pharmacies$16.9K5.6%no prior
- Product$13.7K4.5%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.